The future of precision medicine part 1: challenges and opportunities
The healthcare industry and governments around the world are turning to precision medicine as an opportunity and a potential saviour. Daniel Lim of Allen & Overy discusses the issues around translating the promise of precision medicine into real world clinical practice.
Latest news
Broad secures US discovery win in CRISPR EPO dispute
22-06-2018
The US Court of Appeals for the First Circuit has confirmed that a request to obtain discovery for use in a foreign proceeding, in this case at the European Patent Office, will be denied unless the relevance of that discovery can be shown.
MSF challenges Gilead patent in China
20-06-2018
50 Key Influencers In The Life Sciences
Regions
